Arcus Biosciences, Inc.
NYSE:RCUS
8.53 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -283 | -307 | -267 | 52.83 | -122.858 | -84.71 | -49.594 | -53.082 | -17.97 |
| Depreciation & Amortization
| 10 | 8 | 6 | 3.843 | 4.191 | 3.578 | 3.664 | 2.612 | 1.314 |
| Deferred Income Tax
| 0 | 0 | 0 | 4.772 | 0 | 0 | -2.095 | 0.416 | -0.09 |
| Stock Based Compensation
| 76 | 73 | 65 | 55 | 22 | 8.981 | 3.874 | 0.495 | 0.09 |
| Change In Working Capital
| 22 | -71 | 623 | -375.618 | 208.058 | 0.125 | 1.332 | 24.598 | 3.622 |
| Accounts Receivables
| 28 | 15 | 704 | -17.046 | -0.917 | -0.132 | -0.058 | 0.38 | 0 |
| Inventory
| 0 | 0 | -704 | 14.085 | 21.324 | 1.069 | 0 | 0 | 0 |
| Accounts Payables
| 3 | -1 | 8 | -4.773 | 9.272 | 1.726 | -0.069 | -0.267 | 3.569 |
| Other Working Capital
| -9 | -85 | 615 | -367.884 | 178.379 | -2.538 | 1.401 | 24.865 | 0.053 |
| Other Non Cash Items
| 5 | -9 | 11 | 3.474 | -0.046 | -1.436 | -0.177 | -0.098 | 0.09 |
| Operating Cash Flow
| -170 | -306 | 438 | -256.171 | 111.17 | -73.462 | -42.996 | -25.059 | -12.944 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -6 | -24 | -12 | -26.078 | -3.055 | -1.925 | -3.743 | -5.514 | -4.099 |
| Acquisitions Net
| 0 | 0 | 0 | -22 | 431 | -61.137 | 0 | 0 | -1 |
| Purchases Of Investments
| -1,043 | -788 | -1,241 | -718.865 | -739.658 | -247.755 | -261.552 | -96.83 | -33.762 |
| Sales Maturities Of Investments
| 965 | 1,006 | 837 | 741.075 | 308.346 | 308.892 | 151.855 | 53.273 | 1 |
| Other Investing Activites
| 0 | 0 | 3 | 22 | -431 | 61.137 | -109.697 | -43.557 | -1 |
| Investing Cash Flow
| -84 | 194 | -413 | -3.868 | -434.367 | 59.212 | -113.44 | -49.071 | -38.861 |
| Financing Activities: | |||||||||
| Debt Repayment
| 47 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 228 | 25 | 23 | 220 | 434 | 1.217 | 125.111 | 0.892 | 70.1 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.006 | -0.054 | -0.094 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 2 | 8 | 33 | 12.34 | 4.675 | 1.217 | 3.963 | 107.396 | 70.1 |
| Financing Cash Flow
| 277 | 33 | 33 | 237.34 | 438.675 | 1.123 | 129.074 | 107.396 | 70.1 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 23 | -79 | 58 | -22.699 | 115.478 | -13.127 | -27.362 | 33.266 | 18.295 |
| Cash At End Of Period
| 153 | 130 | 209 | 150.919 | 173.618 | 58.14 | 71.064 | 98.426 | 65.16 |